ALLMedicine™ Lacunar Stroke Center
Research & Reviews 241 results
https://clinicaltrials.gov/ct2/show/NCT03585595
May 10th, 2022 - Stroke is a leading cause of death and long-term disability worldwide, especially in the elderly population. Hypertension is a major risk factor for stroke. Previous clinical trials have documented that blood pressure (BP) reduction lowers the ris...
https://clinicaltrials.gov/ct2/show/NCT05300997
Apr 29th, 2022 - Introduction Stroke is a leading cause of overall mortality, morbidity and disability worldwide. In 2010 it was the second leading cause of death whilst in 2019 it ranked third overall for disability adjusted life years (DALYs) and second for thos...
https://doi.org/10.1080/14656566.2022.2071125
Expert Opinion on Pharmacotherapy; Lattanzi S, Acampa M et. al.
Apr 27th, 2022 - 'Embolic stroke of undetermined source' (ESUS) is a term coined to identify non-lacunar stroke whose mechanism is likely to be embolic, and the source remains unidentified. The best antithrombotic treatment for preventing stroke recurrence in this...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032370
PLoS Medicine; Linden AB, Clarke R et. al.
Apr 23rd, 2022 - Taller adult height is associated with lower risks of ischemic heart disease in mendelian randomization (MR) studies, but little is known about the causal relevance of height for different subtypes of ischemic stroke. The present study examined th...
https://doi.org/10.1161/STROKEAHA.121.037610
Stroke Kerner C, Fadhil A et. al.
Mar 4th, 2022 - Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: A Woman With Lacunar Stroke.|2022|Kerner C,Fadhil A,Sundararajan S,|complications,diagnostic imaging,complications,diagnostic imaging,complications,diagnos...
Drugs 2 results see all →
Clinicaltrials.gov 6 results
https://clinicaltrials.gov/ct2/show/NCT03585595
May 10th, 2022 - Stroke is a leading cause of death and long-term disability worldwide, especially in the elderly population. Hypertension is a major risk factor for stroke. Previous clinical trials have documented that blood pressure (BP) reduction lowers the ris...
https://clinicaltrials.gov/ct2/show/NCT05300997
Apr 29th, 2022 - Introduction Stroke is a leading cause of overall mortality, morbidity and disability worldwide. In 2010 it was the second leading cause of death whilst in 2019 it ranked third overall for disability adjusted life years (DALYs) and second for thos...
https://clinicaltrials.gov/ct2/show/NCT03107637
Jun 22nd, 2021 - The ESUS concept was introduced recently to describe a non-lacunar stroke of undetermined etiology. The following etiological workup is required in this setting: head CT or MRI, 12-lead ECG, transthoracic echocardiography, continuous cardiac monit...
https://clinicaltrials.gov/ct2/show/NCT03874702
May 18th, 2021 - PROBLEM STATEMENT Stroke is the fifth cause of death in the United States and the number one cause of long term disability. Annually around 800,000 persons are diagnosed with stroke in this country, causing the death of around 130,000 persons, eac...
https://clinicaltrials.gov/ct2/show/NCT02310282
Oct 28th, 2016 - Assessment of stroke severity and differentiation between large-artery and small-artery stroke is pivotal for adequate treatment decision taking. Patients with small vessel stroke tend have a better prognosis than those with large artery disease. ...
News 28 results
https://www.medscape.com/viewarticle/966446
Jan 12th, 2022 - Takeaway The prevalence of vascular cognitive impairment (VCI) was higher in patients with lacunar stroke. Why this matters Findings suggest that patients with lacunar stroke should be evaluated using an appropriate cognitive screening tool, such ...
https://www.medscape.com/viewarticle/912635
May 6th, 2019 - Two drugs for heart disease and angina — cilostazol (Pletal, Otsuka) and isosorbide mononitrate (ISMN) (multiple brands) — have neuroprotective potential for patients with lacunar ischemic stroke, new research suggests. Results of the phase 2 LACu...
https://www.mdedge.com/cardiology/article/196736/stroke/intensive-blood-pressure-lowering-may-not-reduce-risk-recurrent
Erik Greb
Mar 20th, 2019 - HONOLULU – Compared with standard treatment, intensive blood pressure reduction does not significantly reduce the risk of recurrent stroke, according to research presented at the International Stroke Conference sponsored by the American Heart Asso.
https://www.staging.medscape.com/viewarticle/907590
Jan 11th, 2019 - A new clinical score has been developed to identify patients with a high risk of early mortality after an ischemic stroke. Previous scores for stroke mortality have been developed, but these have generally looked at late deaths, the researchers sa...
https://www.medscape.com/viewarticle/907590
Jan 11th, 2019 - A new clinical score has been developed to identify patients with a high risk of early mortality after an ischemic stroke. Previous scores for stroke mortality have been developed, but these have generally looked at late deaths, the researchers sa...